SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-031298
Filing Date
2015-04-29
Accepted
2015-04-29 08:29:29
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-7264_110q.htm 10-Q 756072
2 EX-31.1 a15-7264_1ex31d1.htm EX-31.1 12586
3 EX-31.2 a15-7264_1ex31d2.htm EX-31.2 13166
4 EX-32.1 a15-7264_1ex32d1.htm EX-32.1 8295
  Complete submission text file 0001104659-15-031298.txt   4528513

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cldx-20150331.xml EX-101.INS 659346
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cldx-20150331.xsd EX-101.SCH 29519
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cldx-20150331_cal.xml EX-101.CAL 50063
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT cldx-20150331_lab.xml EX-101.LAB 295965
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cldx-20150331_pre.xml EX-101.PRE 191072
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cldx-20150331_def.xml EX-101.DEF 81590
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 15810210
SIC: 2835 In Vitro & In Vivo Diagnostic Substances